IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
13 hedge funds and large institutions have $2.37M invested in Interpace Biosciences, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
13
Holders Change
-4
Holders Change %
-23.53%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
5
Reduced
2
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
+$1.67M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$106K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$91K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$48.1K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$40K |
Top Sellers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$646K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$476K |
| 3 |
WS
Wedbush Securities
Los Angeles,
California
|
-$57.5K |
| 4 |
Bank of New York Mellon
New York
|
-$18K |
| 5 |
Morgan Stanley
New York
|
-$14.3K |
